7SNL
Disulfide stabilized HIV-1 CA hexamer in complex with capsid inhibitor N-(1-(3-(4-chloro-1-methyl-3-(methylsulfonamido)-1H-indazol-7-yl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-(3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetamide
Summary for 7SNL
Entry DOI | 10.2210/pdb7snl/pdb |
Descriptor | Capsid protein p24, N-[(1S)-1-(3-{4-chloro-3-[(methanesulfonyl)amino]-1-methyl-1H-indazol-7-yl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[3-(trifluoromethyl)-6,7-dihydro-1H-indazol-1-yl]acetamide, IODIDE ION, ... (5 entities in total) |
Functional Keywords | viral protein |
Biological source | Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1) |
Total number of polymer chains | 1 |
Total formula weight | 27005.20 |
Authors | Bester, S.M.,Kvaratskhelia, M. (deposition date: 2021-10-28, release date: 2022-10-05, Last modification date: 2023-10-18) |
Primary citation | Adu-Ampratwum, D.,Haney, R.,Bester, S.M.,Annamalai, A.S.,Wei, G.,Fuchs, J.R.,Kvaratskhelia, M. Disulfide stabilized HIV-1 CA hexamer in complex with capsid inhibitor N-(1-(3-(4-chloro-1-methyl-3-(methylsulfonamido)-1H-indazol-7-yl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-(3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetamide To Be Published, |
Experimental method | X-RAY DIFFRACTION (2.39 Å) |
Structure validation
Download full validation report